实体
Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California
Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California
PulseAugur coverage of Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California — every cluster mentioning Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California across labs, papers, and developer communities, ranked by signal.
总计 · 30天
1
90 天内 1
发布 · 30天
0
90 天内 0
论文 · 30天
0
90 天内 0
层级分布 · 90 天
主题
情绪 · 30 天
1 天有情绪数据
最近 · 第 1/1 页 · 共 1 条